Macrophage activation syndrome as an unusual presentation of paucisymptomatic severe acute respiratory syndrome coronavirus 2 infection: A case report

Medicine (Baltimore). 2020 Aug 7;99(32):e21570. doi: 10.1097/MD.0000000000021570.

Abstract

Rationale: Macrophage activation syndrome (MAS) is a rare life-threatening condition characterized by cytokine-mediated tissue injury and multiorgan dysfunction.

Patient concerns: We describe the unique case of young man who developed MAS as the sole manifestation of an otherwise paucisymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Diagnoses: Clinical and biological criteria led to the diagnosis of MAS; cytokine profile was highly suggestive reverse transcription polymerase chain reaction for SARS-CoV-2 in nasopharyngeal swabs was negative, but serum anti-SARS-CoV-2 immunoglobulin A and immunoglobulin G resulted positive leading to the diagnosis of SARS-CoV-2 infection.

Interventions: The patient was treated with empiric antibiotic and hydroxychloroquine.

Outcomes: Clinical improvement ensued. At follow-up, the patient is well.

Lesson: SARS-CoV-2 infection may trigger develop life-threatening complications, like MAS. This can be independent from coronavirus disease 2019 gravity.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Blood Chemical Analysis
  • COVID-19
  • COVID-19 Testing
  • Ceftriaxone / administration & dosage*
  • China
  • Clinical Laboratory Techniques / methods
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / drug therapy
  • DNA, Viral / analysis
  • Diagnosis, Differential
  • Disease Progression
  • Drug Therapy, Combination
  • Electrocardiography / methods
  • Follow-Up Studies
  • Hospitalization*
  • Humans
  • Hydroxychloroquine / administration & dosage*
  • Macrophage Activation Syndrome / diagnosis*
  • Macrophage Activation Syndrome / therapy
  • Male
  • Pandemics
  • Patient Discharge
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / drug therapy
  • Radiography, Thoracic / methods
  • Real-Time Polymerase Chain Reaction / methods
  • Risk Assessment
  • Severity of Illness Index
  • Tomography, X-Ray Computed / methods
  • Treatment Outcome

Substances

  • DNA, Viral
  • Hydroxychloroquine
  • Ceftriaxone